Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Clinical trial NCT04648280 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04648280
Sponsor: PENTA Foundation
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HIV Infections With Multi Drug Resistant Virus

Start date: 2022-06-30
Primary completion: 2028-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.